Clinical Trial: First in Human Safety Study of FX-345 in Adults With Sensorineural Hearing Loss
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Condition: Hearing Loss, Sensorineural
Study Type: Interventional
Official Title: A Phase 1b, Prospective, Randomized, Single-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety of FX-345 Administered as a Single Intratympanic Injection in Adults With Acquired Adult
Brief Summary:
This single-blind, placebo-controlled trial will be conducted to evaluate the safety of FX-345 administered as a single intratympanic injection in adults with acquired sensorineural hearing loss. The primary objectives are to assess the local safety, systemic safety, and pharmacokinetic (PK) profile to determine systemic exposure.
Read more